Treatment Trials

9 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      ET-01 in Subjects With Lateral Canthal Lines, LCL-210
      Description

      This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

      Conditions
      Lateral Canthal Lines, LCLCrow's Feet
      Talk to us
      COMPLETED
      MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
      Description

      To evaluate the long-term safety of MT10109L in the treatment of GL and/or LCL in participants with moderate to severe GL and/or LCL.

      Conditions
      Glabellar LinesLateral Canthal Lines
      Talk to us
      COMPLETED
      ET-01 in Subjects With Lateral Canthal Lines, LCL-209
      Description

      This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

      Conditions
      Lateral Canthal Lines, LCLCrow's Feet
      Talk to us
      COMPLETED
      ET-01 in Subjects With Lateral Canthal Lines, LCL-208
      Description

      This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

      Conditions
      Lateral Canthal LinesCrow's Feet
      Talk to us
      COMPLETED
      MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
      Description

      To evaluate the safety and efficacy of MT10109L for the treatment of glabellar lines (GL) with or without concurrent treatment of lateral canthal lines (LCL) in participants with moderate to severe GL and LCL.

      Conditions
      Glabellar LinesLateral Canthal Lines
      Talk to us
      COMPLETED
      ET-01 in Subjects With Lateral Canthal Lines, LCL-207
      Description

      This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

      Conditions
      Lateral Canthal LinesCrow's Feet
      Talk to us
      COMPLETED
      Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
      Description

      This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

      Conditions
      Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
      Talk to us
      COMPLETED
      Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
      Description

      A Phase 2a, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Treatment of Moderate or Severe Lateral Canthal Lines (LCL).

      Conditions
      Lateral Canthal Lines
      Talk to us
      COMPLETED
      Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
      Description

      This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of DaxibotulinumtoxinA for injection (DAXI for injection) in the treatment of Glabellar Lines (GL), Dynamic Forehead Lines (FHL), and Lateral Canthal Lines(LCL)

      Conditions
      Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
      Talk to us